Radiance Study

Relapsing Multiple Sclerosis

Want to learn about
our experience
in this therapeutic area?

Contact us today.


This study was testing an oral treatment option that would help patients with relapsing multiple sclerosis manage symptoms and treat relapses. And it was to be conducted in the U.S. as well as 20 countries across the world. Our task was to create a message and campaign materials that could easily be translated and would resonate appropriately in all 21 countries.


While materials were used in some form in all 21 countries, the campaign was customized for each – with locations only using materials that would be useful and approved by regulatory authorities. In the U.S., we launched a media campaign that included paid search, online display, and Facebook advertising. Our online advertising campaign generated more than 10 million impressions and provided 78% of the nearly 30,000 visitors to the study website. Screening ended three months early, and the enrollment total for the U.S. exceeded our goals.

At a Glance